Vaccines for Cancer Immunotherapy
An Evidence-Based Review on Current Status and Future Perspectives
- 1st Edition - October 17, 2018
- Latest edition
- Editors: Nima Rezaei, Mahsa Keshavarz-Fathi
- Language: English
Therapeutic cancer vaccines represent a type of active cancer immunotherapy. Clinicians, scientists, and researchers working on cancer treatment require evidence-based and up… Read more
End of Summer Sale
Save up to 30% off
Bright savings for research, study, and discovery
Description
Description
Therapeutic cancer vaccines represent a type of active cancer immunotherapy. Clinicians, scientists, and researchers working on cancer treatment require evidence-based and up-to-date resources relating to therapeutic cancer vaccines. Vaccines for Cancer Immunotherapy provides a reference for cancer treatment for clinicians and presents a well-organized resource for determining high-potential research areas. The book considers that this promising modality can be made more feasible as a treatment for cancer. Chapters cover cancer immunology, general approaches to cancer immunotherapy, vaccines, tumor antigens, the strategy of allogeneic and autologous cancer vaccines, personalized vaccines, whole-tumor antigen vaccines, protein and peptide vaccines, dendritic cell vaccines, genetic vaccines, candidate cancers for vaccination, obstacles to developing therapeutic cancer vaccines, combination therapy, future perspectives and concluding remarks on therapeutic cancer vaccines.
Key features
Key features
- Introduces the feasible immunotherapeutic vaccines for patients with different types of cancer
- Presents the status of past and current vaccines for cancer treatment
- Considers advantages and disadvantages of different therapeutic cancer vaccines
- Looks at the combination of vaccines and other modalities, including immunotherapeutic and conventional methods
- Analyzes obstacles to development of therapeutic cancer vaccines
- Gives a view on future perspectives in the application of therapeutic cancer vaccines
Readership
Readership
Interdisciplinary: clinicians, scientists and researchers working on applying different modalities for cancer treatment, including biological therapies; immunologists, oncologists, biotechnologists, and other specialists dealing with cancer research and therapy
Table of contents
Table of contents
1. Cancer immunology
2. Immunotherapeutic Approaches in Cancer
3. Vaccines, Adjuvants, and Delivery Systems
4. Tumor Antigens
5. Strategy of Allogeneic and Autologous Cancer Vaccines
6. Personalized Cancer Vaccine
7. Whole Tumor Cell Vaccine for Cancer
8. Peptide and Protein Vaccines for Cancer
9. Immune Cell Vaccine for Cancer
10. Genetic Vaccine for Cancer
11. Candidate Cancers for Vaccination
12. Obstacles in the Development of Therapeutic Cancer Vaccines
13. Combination Therapy: Cancer Vaccines and Other Therapeutics
14. Concluding Remarks and Future Perspectives on Therapeutic Cancer Vaccines
Product details
Product details
- Edition: 1
- Latest edition
- Published: October 17, 2018
- Language: English
About the editors
About the editors
NR
Nima Rezaei
Nima Rezaei, MD, PhD, is Professor of Clinical Immunology and Allergy at Tehran University of Medical Sciences, where he also serves as Associate Dean of International Affairs for the School of Medicine and Director of the Global Academic Program. He is Deputy President of the Research Center for Immunodeficiencies and holds an affiliated research appointment in the Division of Clinical Immunology, Department of Laboratory Medicine, Karolinska Institutet, Sweden. He earned his MD from Tehran University of Medical Sciences and his PhD in Clinical Immunology and Human Genetics from the University of Sheffield, United Kingdom. His research addresses primary immunodeficiencies and translational immunology, with recent work extending into computational and AI-based approaches to immune profiling. He is the founder and President of the Universal Scientific Education and Research Network (USERN) and serves as co-editor of the Springer Nature series Advances in Experimental Medicine and Biology.
MK